The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Diabetes and cancer: two diseases with obesity as a common risk factor
Open accessAbstract
There is a growing body of evidence to support a connection between diabetes (predominantly type 2), obesity and cancer. Multiple meta‐analyses of epidemiological data show that people with diabetes are at increased risk of developing many different types of cancers, along with an increased risk of cancer mortality. Several pathophysiological mechanisms for this relationship have been postulated, including insulin resistance and hyperinsulinaemia, enhanced inflammatory processes, dysregulation of sex hormone production and hyperglycaemia. In addition to these potential mechanisms, a number of common risk factors, including obesity, may be behind the association between diabetes and cancer. Indeed, obesity is associated with an increased risk of cancer and diabetes. Abdominal adiposity has been shown to play a role in creating a systemic pro‐inflammatory environment, which could result in the development of both diabetes and cancer. Here, we examine the relationship between diabetes, obesity and cancer, and investigate the potential underlying causes of increased cancer risk in individuals with diabetes. Current treatment recommendations for reducing the overall disease burden are also explored and possible areas for future research are considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies
Elashoff, M., Matveyenko, A. V., Gier, B., Elashoff, R., & Butler, P. C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.018 · Cited by 944
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881 · cited 3×
“In particular, a significant increase in mortality risk was observed for endometrial, breast and colorectal cancers [2,61].”
BackgroundJiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“There is also some evidence to suggest that people with diabetes may be less responsive to chemotherapy than people without diabetes [73].”
BackgroundDiabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
Everhart, J. (1995) · JAMA · doi:10.1001/jama.273.20.1605 · Cited by 742
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Vaughn, D. J., Nessel, L., Selby, J., & Strom, B. L. (2011) · Diabetes Care · doi:10.2337/dc10-1068 · Cited by 625
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.039 · Cited by 621
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Lahmann, P. H., Hoffmann, K., Allen, N., van Gils, C. H., Khaw, K., Tehard, B., Berrino, F., Tjønneland, A., Bigaard, J., Olsen, A., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20315 · Cited by 580
Obesity and cancer risk: evidence, mechanisms, and recommendations
Vucenik, I., & Stains, J. P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06750.x · Cited by 571
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Pannala, R., Basu, A., Petersen, G. M., & Chari, S. T. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70337-1 · Cited by 558
Pischon, T., Lahmann, P. H., Boeing, H., Friedenreich, C., Norat, T., Tjønneland, A., Halkjaer, J., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M.-C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj246 · Cited by 554
Glucocorticoid-induced hyperglycemia
Clore, J. N., & Thurby-Hay, L. (2009) · Endocrine Practice · doi:10.4158/ep08331.rar · Cited by 508
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess
Wellen, K. E., & Thompson, C. B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.004 · Cited by 486
Griggs, J. J., Mangu, P. B., Anderson, H., Balaban, E. P., Dignam, J. J., Hryniuk, W. M., Morrison, V. A., Pini, T. M., Runowicz, C. D., Rosner, G. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.9436 · Cited by 485
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Singh, S., Chang, H.-Y., Richards, T. M., Weiner, J. P., Clark, J. M., & Segal, J. B. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2720 · Cited by 467
Butler, A. E., Campbell-Thompson, M., Gurlo, T., Dawson, D. W., Atkinson, M., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1686 · Cited by 457
Prospective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women
Hu, F. B., Manson, J. E., Liu, S., Hunter, D., Colditz, G. A., Michels, K. B., Speizer, F. E., & Giovannucci, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.542 · Cited by 423
Diabetes mellitus and breast cancer
Wolf, I., Sadetzki, S., Catane, R., Karasik, A., & Kaufman, B. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01736-5 · Cited by 422
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Frasca, F., Pandini, G., Sciacca, L., Pezzino, V., Squatrito, S., Belfiore, A., & Vigneri, R. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801969715 · Cited by 410
Stattin, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1910 · Cited by 404
Silverman, D. T., Schiffman, M., Everhart, J., Goldstein, A., Lillemoe, K. D., Swanson, G. M., Schwartz, A. G., Brown, L. M., Greenberg, R. S., Schoenberg, J. B., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690607 · Cited by 397
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Metformin: Taking away the candy for cancer?
Jalving, M., Gietema, J. A., Lefrandt, J. D., Jong, S. D., Reyners, A. K. L., Gans, R. O. B., & Vries, E. G. E. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.012 · Cited by 380
Impact of Diabetes Mellitus on Outcomes in Patients With Colon Cancer
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Macdonald, J. S., Benson, A. B., & Fuchs, C. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.125 · Cited by 374
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
Yang, Y., Hennessy, S., & Lewis, J. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.011 · Cited by 350
Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study
Michels, K. B., Solomon, C. G., Hu, F. B., Rosner, B. A., Hankinson, S. E., Colditz, G. A., & Manson, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1752 · Cited by 341
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Dore, D. D., Seeger, J. D., & Arnold Chan, K. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902820519 · Cited by 326
van de Poll‐Franse, L. V., Houterman, S., Janssen‐Heijnen, M. L. G., Dercksen, M. W., Coebergh, J. W. W., & Haak, H. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22532 · Cited by 324
Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin
Garg, R., Chen, W., & Pendergrass, M. (2010) · Diabetes Care · doi:10.2337/dc10-0482 · Cited by 322
Obesity and colon cancer: Does leptin provide a link?
Stattin, P., Lukanova, A., Biessy, C., Söderberg, S., Palmqvist, R., Kaaks, R., Olsson, T., & Jellum, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.11668 · Cited by 319
Does diabetes therapy influence the risk of cancer?
Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316
Diabetes mellitus and risk of bladder cancer: a meta-analysis
Larsson, S. C., Orsini, N., Brismar, K., & Wolk, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0468-0 · Cited by 304
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Duggan, C., Irwin, M. L., Xiao, L., Henderson, K. D., Smith, A. W., Baumgartner, R. N., Baumgartner, K. B., Bernstein, L., Ballard-Barbash, R., & McTiernan, A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4473 · Cited by 294
Undertreatment of Obese Women Receiving Breast Cancer Chemotherapy
Griggs, J. J., Sorbero, M. E. S., & Lyman, G. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1267 · Cited by 289
Metformin and cancer: new applications for an old drug
Kourelis, T. V., & Siegel, R. D. (2012) · Medical Oncology · doi:10.1007/s12032-011-9846-7 · Cited by 289
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
Richardson, L. C., & Pollack, L. A. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0062 · Cited by 289
Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
Parks, M., & Rosebraugh, C. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1001578 · Cited by 275
on behalf of the Diabetes and Cancer Research Consortium, Johnson, J. A., Carstensen, B., Witte, D., Bowker, S. L., Lipscombe, L., & Renehan, A. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2525-1 · Cited by 260
Friedenreich, C., Norat, T., Steindorf, K., Boutron-Ruault, M.-C., Pischon, T., Mazuir, M., Clavel-Chapelon, F., Linseisen, J., Boeing, H., Bergman, M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0595 · Cited by 234
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Tachibana, K., Yamasaki, D., Ishimoto, K., & Doi, T. (2008) · PPAR Research · doi:10.1155/2008/102737 · Cited by 223
Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer
Tsujinaka, S., Konishi, F., Kawamura, Y. J., Saito, M., Tajima, N., Tanaka, O., & Lefor, A. T. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9395-0 · Cited by 213
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
Bansal, D., Bhansali, A., Kapil, G., Undela, K., & Tiwari, P. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.40 · Cited by 206
Weiser, M. A., Cabanillas, M. E., Konopleva, M., Thomas, D. A., Pierce, S. A., Escalante, C. P., Kantarjian, H. M., & O'Brien, S. M. (2004) · Cancer · doi:10.1002/cncr.20071 · Cited by 204
Diabetes, prediabetes and cancer mortality
for the DECODE Study Group, Zhou, X. H., Qiao, Q., Zethelius, B., Pyörälä, K., Söderberg, S., Pajak, A., Stehouwer, C. D. A., Heine, R. J., Jousilahti, P., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1796-7 · Cited by 197
Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?
McIntosh, C. H. S., Demuth, H.-U., Pospisilik, J. A., & Pederson, R. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.001 · Cited by 192
Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast Cancer
Erickson, K., Patterson, R. E., Flatt, S. W., Natarajan, L., Parker, B. A., Heath, D. D., Laughlin, G. A., Saquib, N., Rock, C. L., & Pierce, J. P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.3183 · Cited by 189
Alves, C., Batel-Marques, F., & Macedo, A. F. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.008 · Cited by 186
Postoperative Mortality in Cancer Patients With Preexisting Diabetes
Barone, B. B., Yeh, H.-C., Snyder, C. F., Peairs, K. S., Stein, K. B., Derr, R. L., Wolff, A. C., & Brancati, F. L. (2010) · Diabetes Care · doi:10.2337/dc09-1721 · Cited by 185
The Association of Obesity and Cervical Cancer Screening: A Systematic Review and Meta‐analysis
Maruthur, N. M., Bolen, S. D., Brancati, F. L., & Clark, J. M. (2009) · Obesity · doi:10.1038/oby.2008.480 · Cited by 183
Weinstein, D., Simon, M., Yehezkel, E., Laron, Z., & Werner, H. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.912 · Cited by 179
Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study
Friberg, E., Mantzoros, C. S., & Wolk, A. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0751 · Cited by 172
The Impact of Obesity on Perioperative Outcomes After Laparoscopic Colorectal Resection
Makino, T., Shukla, P. J., Rubino, F., & Milsom, J. W. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31823dcbf7 · Cited by 170
Bowker, S. L., Yasui, Y., Veugelers, P., & Johnson, J. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1750-8 · Cited by 165
Yang, X., Ko, G. T. C., So, W. Y., Ma, R. C. W., Yu, L. W. L., Kong, A. P. S., Zhao, H., Chow, C.-C., Tong, P. C. Y., & Chan, J. C. N. (2010) · Diabetes · doi:10.2337/db09-1371 · Cited by 162
Stevens, R. J., Ali, R., Bankhead, C. R., Bethel, M. A., Cairns, B. J., Camisasca, R. P., Crowe, F. L., Farmer, A. J., Harrison, S., Hirst, J. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2653-7 · Cited by 161
Diabetes and pancreatic cancer
Cui, Y., & Andersen, D. K. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0105 · Cited by 159
Comorbidity as a Predictor of Stage of Illness for Patients With Breast Cancer
Fleming, S. T., Pursley, H. G., Newman, B., Pavlov, D., & Chen, K. (2005) · Medical Care · doi:10.1097/00005650-200502000-00006 · Cited by 158
Is obesity an inflammatory disease?
Ramos, E. J. B., Xu, Y., Romanova, I., Middleton, F. A., Chen, C., Quinn, R., Inui, A., Das, U. N., & Meguid, M. M. (2003) · Surgery · doi:10.1067/msy.2003.267 · Cited by 152
Bosco, J. L. F., Antonsen, S., Sørensen, H. T., Pedersen, L. H., & Lash, T. L. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0817 · Cited by 151
Insulin glargine and malignancy: an unwarranted alarm
Pocock, S., & Smeeth, L. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61307-6 · Cited by 150
Body Mass Index, Waist Circumference, and the Risk of Type 2 Diabetes Mellitus
Feller, S., Boeing, H., & Pischon, T. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0470 · Cited by 149
Campbell, P. T., Deka, A., Jacobs, E. J., Newton, C. C., Hildebrand, J. S., McCullough, M. L., Limburg, P. J., & Gapstur, S. M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.072 · Cited by 148
A cohort study of acute pancreatitis in relation to exenatide use
Dore, D. D., Bloomgren, G., Wenten, M., Hoffman, C., Clifford, C. R., Quinn, S. G., Braun, D. K., Noel, R. A., & Seeger, J. D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01376.x · Cited by 145
Obesity and Mammography: A Systematic Review and Meta-Analysis
Maruthur, N. M., Bolen, S. D., Brancati, F. L., & Clark, J. M. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0939-3 · Cited by 144
Diabetes mellitus and pancreaticcancer mortality in a prospectivecohort of United States adults
Calle, E. E., Murphy, T. K., Rodriguez, C., Thun, M. J., & Heath, C. W. (1998) · Cancer Causes & Control · doi:10.1023/a:1008819701485 · Cited by 143
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
Engel, S. S., Williams‐Herman, D., Golm, G. T., Clay, R. J., Machotka, S. V., Kaufman, K. D., & Goldstein, B. J. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02382.x · Cited by 143
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
Perks, C. M., Vernon, E. G., Rosendahl, A. H., Tonge, D. W., & Holly, J. M. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210397 · Cited by 143
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
Home, P., & Lagarenne, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1530-5 · Cited by 142
Diabetes and Risk of Non-Hodgkin's Lymphoma
Mitri, J., Castillo, J. J., & Pittas, A. G. (2008) · Diabetes Care · doi:10.2337/dc08-1034 · Cited by 142
Rosenstock, J., Fonseca, V., McGill, J. B., Riddle, M., Hallé, J. P., Hramiak, I., Johnston, P., & Davis, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1452-2 · Cited by 141
Grote, V. A., Rohrmann, S., Nieters, A., Dossus, L., Tjønneland, A. M., Halkjær, J., Overvad, K., Fagherazzi, G., Boutron‐Ruault, M., Morois, S., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2316-0 · Cited by 138
Pischon, T., Boeing, H., Weikert, S., Allen, N. E., Key, T., Johnsen, N. F., Tjønneland, A. M., Severinsen, M. T., Overvad, K., Rohrmann, S., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0609 · Cited by 134
Steffen, A., Schulze, M. B., Pischon, T., Dietrich, T., Molina‐Montes, E., Chirlaque, M., Barricarte, A., Amiano, P., Quirós, J. R., Tumino, R., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0265 · Cited by 128
Insulin-like growth factor-I and cancer risk
Ibrahim, Y. H., & Yee, D. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.01.005 · Cited by 121
LeRoith, D., Novosyadlyy, R., Gallagher, E. J., Lann, D. E., Vijayakumar, A., & Yakar, S. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1081488 · Cited by 120
de González, A. B., Spencer, E. A., Bueno-de-Mesquita, H. B., Roddam, A., Stolzenberg-Solomon, R. Z., Halkjær, J., Tjønneland, A. M., Overvad, K., Clavel‐Chapelon, F., Boutron‐Ruault, M., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0800 · Cited by 117
Insulin receptors in breast cancer: Biological and clinical role
Papa, V., & Belfiore, A. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03347871 · Cited by 116
Impact of Diabetes and Hyperglycemia on Survival in Advanced Breast Cancer Patients
Villarreal-Garza, C. M., Shaw-Dulin, R. J., Lara-Medina, F. U., Bacon, L., Rivera, D., Urzua, L., Águila, C., Ramírez-Morales, R., Santamaria, J., Bargalló, E., et al. (2012) · Experimental Diabetes Research · doi:10.1155/2012/732027 · Cited by 115
Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Mannucci, E., Monami, M., Balzi, D., Cresci, B., Pala, L., Melani, C., Lamanna, C., Bracali, I., Bigiarini, M., Barchielli, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0476 · Cited by 114
Zeng, L., Biernacka, K. M., Holly, J. M. P., Jarrett, C., Morrison, A. A., Morgan, A., Winters, Z., Foulstone, E. J., Hamilton-Shield, J. P., & Perks, C. M. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0221 · Cited by 113
Brunello, A., Kapoor, R., & Extermann, M. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181e1d0c0 · Cited by 112
Dejgaard, A., Lynggaard, H., Råstam, J., & Thomsen, M. (2009) · Diabetologia · doi:10.1007/s00125-009-1568-4 · Cited by 109
Ben, Q., Cai, Q.-C., Li, Z., Yuan, Y., Ning, X., Deng, S., & Wang, K. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.010 · Cited by 105
A prospective study of weight change and systemic inflammation over 9 y
Fogarty, A., Glancy, C., Jones, S. G., Lewis, S., McKeever, T. M., & Britton, J. R. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.30 · Cited by 98
Rosiglitazone and Risk of Cancer
Monami, M., Lamanna, C., Marchionni, N., & Mannucci, E. (2008) · Diabetes Care · doi:10.2337/dc07-2308 · Cited by 97
The complexities of obesity and diabetes with the development and progression of pancreatic cancer
Bao, B., Wang, Z., Li, Y., Kong, D., Ali, S. S., Banerjee, S., Ahmad, A., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.11.003 · Cited by 96
The Underuse of Screening Services Among Elderly Women With Diabetes
McBean, A. M., & Yu, X. (2007) · Diabetes Care · doi:10.2337/dc06-2233 · Cited by 94
Diabetes and endometrial cancer: An Italian case-control study
Parazzini, F., Vecchia, C. L., Negri, E., Riboldi, G., Surace, M., Benzi, G., Maina, A., & Chiaffarino, F. (1999) · International Journal of Cancer · Cited by 93
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
Lam, E. K. K., Batty, G. D., Huxley, R., Martiniuk, A. L. C., Barzi, F., Lam, T., Lawes, C. M. M., Giles, G. G., Welborn, T. A., Ueshima, H., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq405 · Cited by 92
Tatarkiewicz, K., Smith, P. A., Sablan, E. J., Polizzi, C. J., Aumann, D. E., Villescaz, C., Hargrove, D. M., Gedulin, B. R., Lu, M. G. W., Adams, L., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00479.2010 · Cited by 91
The impact of obesity on outcomes of laparoscopic surgery for colorectal cancer in Asians
Park, J. W., Lim, S.-W., Choi, H. S., Jeong, S., Oh, J. H., & Lim, S. (2009) · Surgical Endoscopy · doi:10.1007/s00464-009-0829-0 · Cited by 88
Turturro, F., Friday, E., & Welbourne, T. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-96 · Cited by 86
Percik, R., & Stümvoll, M. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1241870 · Cited by 85
Nimptsch, K., Kenfield, S. A., Jensen, M. K., Stampfer, M. J., FRANZ, M. M., Sampson, L., Brand-Miller, J. C., Willett, W. C., & Giovannucci, E. L. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9671-x · Cited by 84
Fenton, J. I., Hord, N. G., Lavigne, J. A., Perkins, S. N., & Hursting, S. D. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0916 · Cited by 83
Feng, J. ‐., Yuan, X., Li, M., Fang, J., Xie, T., Zhou, Y., Zhu, Y., Luo, M.-H., Lin, M., & Ye, D. ‐. (2012) · Colorectal Disease · doi:10.1111/j.1463-1318.2012.03097.x · Cited by 82
Association between tamoxifen treatment and diabetes: A population‐based study
Lipscombe, L. L., Fischer, H. D., Yun, L., Gruneir, A., Austin, P. C., Paszat, L. F., Anderson, G., & Rochon, P. A. (2011) · Cancer · doi:10.1002/cncr.26559 · Cited by 81
History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
Li, Q., Kuriyama, S., Kakizaki, M., YAN, H. H., Sone, T., Nagai, M., Sugawara, Y., Ohmori‐Matsuda, K., Hozawa, A., Nishino, Y., et al. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9530-9 · Cited by 77
Obesity Increases Wound Complications in Rectal Cancer Surgery
Balentine, C. J., Wilks, J. A., Robinson, C. N., Marshall, C. L., Anaya, D., Albo, D., & Berger, D. H. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.03.012 · Cited by 76
Wenten, M., Gaebler, J. A., Hussein, M. A., Pelletier, E. M., Smith, D. B., Girase, P. G., Noel, R. A., Braun, D. K., & Bloomgren, G. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03652.x · Cited by 75
Wong, J. R., Gao, Z., Merrick, S., Wilson, P., Uematsu, M., Woo, K. Y., & Cheng, C.-W. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.049 · Cited by 72
Burton, J. D., Goldenberg, D. M., & Blumenthal, R. D. (2008) · PPAR Research · doi:10.1155/2008/494161 · Cited by 71
Screening Mammogram Utilization in Women With Diabetes
Beckman, T. J., Cuddihy, R. M., Scheitel, S. M., Naessens, J. M., Killian, J. M., & Pankratz, V. S. (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2049 · Cited by 69
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
Pierce, B. L. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.07.008 · Cited by 68
Turner, E. L., Lane, J. A., Donovan, J., Davis, M., Metcalfe, C., Neal, D. E., Hamdy, F. C., & Martin, R. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25360 · Cited by 66
DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells
Masur, K., Schwartz, F., Entschladen, F., Niggemann, B., & Zaenker, K. S. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.07.003 · Cited by 65
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
Wolf, I., Sadetzki, S., Gluck, I., Oberman, B., Ben-David, M. A., Papa, M. Z., Catane, R., & Kaufman, B. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.027 · Cited by 63
Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
Ali, A. S., Ali, S., Ahmad, A., Bao, B., Philip, P. A., & Sarkar, F. H. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00906.x · Cited by 58
Hormonal profile of diabetic men and the potential link to prostate cancer
Kasper, J. S., Liu, Y., Pollak, M., Rifai, N., & Giovannucci, E. L. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9133-x · Cited by 58
Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Chao, C., & Page, J. H. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn160 · Cited by 56
Pandey, V., Chaube, B., & Bhat, M. K. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23210 · Cited by 54
Alokail, M. S., Al‐Daghri, N. M., Al-Attas, O. S., & Hussain, T. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-33 · Cited by 54
Štulc, T., & Šedo, A. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.02.017 · Cited by 53
The Pathway from Diabetes and Obesity to Cancer, on the Route to Targeted Therapy
Gallagher, E. J., Fierz, Y., Ferguson, R. D., & LeRoith, D. (2010) · Endocrine Practice · doi:10.4158/ep10098.ra · Cited by 51
Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
Johnson, J. A., & Pollak, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1855-0 · Cited by 48
Williams, G. P. (2010) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328338f7d2 · Cited by 42
Do cancer cells care if their host is hungry?
Pollak, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.04.006 · Cited by 38
Diabetes mellitus, other medical conditions and pancreatic cancer: a case‐control study
Lipworth, L. P., Zucchetto, A., Bosetti, C., Franceschi, S., Talamini, R., Serraino, D., McLaughlin, J. K., Vecchia, C. L., & Negri, E. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1162 · Cited by 31
The Association between Obesity and Colorectal Cancer
Whitlock, K. A., Gill, R. S., Birch, D. W., & Karmali, S. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/768247 · Cited by 21
Gier, B., & Butler, P. C. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3374 · Cited by 17
Diabetes and Cancer: Epidemiological, Clinical, and Experimental Perspectives
Tseng, C., Chen, C., & Landolph, J. R. (2012) · Experimental Diabetes Research · doi:10.1155/2012/101802 · Cited by 14
Selection of chemotherapy for patients with advanced non–small cell lung cancer
Pennell, N. A. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78.s2.10 · Cited by 14
Diabetes Mellitus and Breast Cancer
Wolf, I., & Rubinek, T. (2008) · Frontiers in diabetes · doi:10.1159/000152028 · Cited by 13
The International Study of Insulin and Cancer
Grimaldi‐Bensouda, L., Marty, M. E., Pollak, M., Cameron, D., Riddle, M. C., Charbonnel, B. H., Barnett, A. H., Boffetta, P., Boivin, J.-F., Evans, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61374-8 · Cited by 11
Prostate Carcinogenesis with Diabetes and Androgen-Deprivation-Therapy-Related Diabetes: An Update
Hara, N. (2012) · Experimental Diabetes Research · doi:10.1155/2012/801610 · Cited by 11
Landman, G. W. D., van Hateren, K. J. J., Kleefstra, N., & Bilo, H. J. G. (2010) · PubMed · Cited by 6
Little, M. W., Pugh, T. F., Carey, F. J., Ndokera, R., Ing, H., Robinson, R. J., Dennison, A. R., Metcalfe, M. S., Clark, A., & Hart, A. R. (2011) · Gut · doi:10.1136/gut.2011.239301.161 · Cited by 5
Research on the relationships between pancreatic cancer and hyperglycemia in C hinese populations
Huang, S., Ye, H., Wu, W., Chen, C., Li, J., Fu, D., & Li, Y. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00237.x · Cited by 4
Cited by
Safaei, M., Sundararajan, E. A., Driss, M., Boulila, W., & Shapi'i, A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104754 · Cited by 720
Hébert, J. R., Shivappa, N., Wirth, M. D., Hussey, J. R., & Hurley, T. G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy071 · Cited by 552
Proença, C., Freitas, M., Ribeiro, D., Oliveira, E. F. T., Sousa, J. L. C., Tomé, S. M., Ramos, M. J., Silva, A. M. S., Fernandes, P. A., & Fernandes, E. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1368503 · Cited by 432
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Halbrook, C. J., & Lyssiotis, C. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.006 · Cited by 393
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
Metadata
- Authors
- Garg, S. K., Maurer, H., Reed, K., & Selagamsetty, R.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2013-06-12
- Volume
- 16
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2043984491
- Cited by
- 275
- References
- 166
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.